Idiopathic pulmonary fibrosis
Conditions
Interventions
Control group:Placebo
Sponsors
Shuguang Hospital Affiliated to Shanghai University of TCM
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who meet the IPF diagnostic criteria of Western medicine; 2. Patients who meet the TCM diagnostic criteria of kidney deficiency and collateral stasis type; 3. Patients aged 50-85 years, both male and female; 4. Patients with good compliance; 5. Patients who voluntarily participate in the experiment and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Acute exacerbation or fulminant patients or late critical patients; 2. Patients with severe primary diseases such as cardiovascular, liver, kidney and hematopoietic system and mental illness; 3. Patients with other acute diseases such as infection, fever and bleeding; 4. Pregnant or lactating women; 5. Patients who are known to be allergic to test drug ingredients; 6. Patients who participated in other clinical studies in recent 3 months; 7. Patients who are not willing to receive trial treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HRCT;TCM syndrome integral and single main symptom integral; | — |
Secondary
| Measure | Time frame |
|---|---|
| six minutes walk distance;St. George's respiratory questionnaire;modified medical research council;Pulmonary function;Blood gas analysis;Serum cytokines; | — |
Countries
China
Contacts
Public ContactWei Zhang
Shuguang Hospital Affiliated to Shanghai University of TCM
Outcome results
None listed